Sulforaphane ameliorates the insulin responsiveness and the lipid profile but does not alter the antioxidant response in diabetic rats.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Food & Function

• Publication date

  2016-04-20

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1039/c5fo01620gPMID 27025193
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sulforaphane attenuates obesity by inhibiting adipogenesis and activating the AMPK pathway in obese mice.

  2014cited by this paper
• Combating oxidative stress in diabetic complications with Nrf2 activators: How much is too much?

  2014cited by this paper
• Chronic sulforaphane oral treatment accentuates blood glucose impairment and may affect GLUT3 expression in the cerebral cortex and hypothalamus of rats fed with a highly palatable diet.

  2013cited by this paper
• Diagnosis and Classification of Diabetes Mellitus

  2013cited by this paper
• Prevention by sulforaphane of diabetic cardiomyopathy is associated with up-regulation of Nrf2 expression and transcription activation.

  2013cited by this paper
• Renal function in diabetic disease models: the tubular system in the pathophysiology of the diabetic kidney.

  2012cited by this paper
• Global health and primary care: increasing burden of chronic diseases and need for integrated training.

  2012cited by this paper
• Diabetes mellitus and thrombosis.

  2012cited by this paper
• Protective effect of sulforaphane against oxidative stress: recent advances.

  2012cited by this paper
• Pathophysiology of Diabetes

  2012cited by this paper
• Prevention of Diabetic Nephropathy by Sulforaphane: Possible Role of Nrf2 Upregulation and Activation

  2012cited by this paper
• Metabolic Effects of Sulforaphane Oral Treatment in Streptozotocin-Diabetic Rats

  2012cited by this paper
• Diagnosis and Classification of Diabetes Mellitus

  2011cited by this paper
• Insulitis in human type 1 diabetes

  2011cited by this paper
• Influence of rutin treatment on biochemical alterations in experimental diabetes.

  2010cited by this paper
• Oxidative stress and diabetic complications.

  2010cited by this paper
• From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus

  2009cited by this paper
• Sulforaphane protects against cytokine- and streptozotocin-induced beta-cell damage by suppressing the NF-kappaB pathway.

  2009cited by this paper
• The insulin-antagonistic effect of the counterregulatory hormones.

  1991cited by this paper
• Catalase in vitro.

  1984cited by this paper
• The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase.

  1972cited by this paper
• Tissue sulfhydryl groups.

  1959cited by this paper

• Oral Sulforaphane Intervention Protects Against Diabetic Cardiomyopathy in db/db Mice: Focus on Cardiac Lipotoxicity and Substrate Metabolism

  2025cites this paper
• Bioactive sulforaphane from cruciferous vegetables: advances in biosynthesis, metabolism, bioavailability, delivery, health benefits, and applications

  2024influential citation
• New horizons for promising influences of sulforaphane in the management of metabolic syndrome: a mechanistic review

  2024cites this paper
• Unveiling the Nutritional Veil of Sulforaphane: With a Major Focus on Glucose Homeostasis Modulation

  2024cites this paper
• Beneficial role of broccoli and its active ingredient, sulforaphane in the treatment of diabetes

  2023cites this paper
• Sulforaphane: a nutraceutical against diabetes-related complications.

  2023cites this paper
• Therapeutic potential of sulforaphane in liver diseases: a review

  2023cites this paper
• Effects of Allyl Isothiocyanate on Oxidative and Inflammatory Stress in Type 2 Diabetic Rats

  2022cites this paper
• Sulforaphane Regulates Glucose and Lipid Metabolisms in Obese Mice by Restraining JNK and Activating Insulin and FGF21 Signal Pathways.

  2021cites this paper
• Glucosinolates

  2021cites this paper
• Sulforaphane prevents type 2 diabetes-induced nephropathy via AMPK-mediated activation of lipid metabolic pathways and Nrf2 anti-oxidative function.

  2020cites this paper
• Sulforaphane ameliorates lipid profile in rodents: an updated systematic review and meta-analysis

  2020cites this paper
• The protective effect of sulforaphane on type II diabetes induced by high‐fat diet and low‐dosage streptozotocin

  2020cites this paper
• Concerted redox modulation by sulforaphane alleviates diabetes and cardiometabolic syndrome.

  2018cites this paper
• New highlights on the health-improving effects of sulforaphane.

  2018cites this paper
• Protective Effects of Sulforaphane on Cognitive Impairments and AD-like Lesions in Diabetic Mice are Associated with the Upregulation of Nrf2 Transcription Activity.

  2018cites this paper
• Sulforaphane Protects against High Cholesterol-Induced Mitochondrial Bioenergetics Impairments, Inflammation, and Oxidative Stress and Preserves Pancreatic β-Cells Function

  2017cites this paper
• Activation of Nrf2 signaling by natural products-can it alleviate diabetes?

  2017cites this paper
• Glucosinolate and Desulfo-glucosinolate Metabolism by a Selection of Human Gut Bacteria

  2016cites this paper